<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhong S</submitter><funding>National Natural Science Foundation of China</funding><funding>Young Talents Program of Jiangsu Cancer Hospital</funding><funding>Huai‘an Natural Science Research Plan</funding><pagination>e11561</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8183431</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9</volume><pubmed_abstract>N6-methyladenosine (m&lt;sup>6&lt;/sup>A) modification has been shown to participate in tumorigenesis and metastasis of human cancers. The present study aimed to investigate the roles of m&lt;sup>6&lt;/sup>A RNA methylation regulators in breast cancer. We used LASSO regression to identify m&lt;sup>6&lt;/sup>A-related gene signature predicting breast cancer survival with the datasets downloaded from Gene Expression Omnibus and The Cancer Genome Atlas (TCGA). RNA-Seq data of 3409 breast cancer patients from GSE96058 and 1097 from TCGA were used in present study. A 10 m&lt;sup>6&lt;/sup>A-related gene signature associated with prognosis was identified from 22 m&lt;sup>6&lt;/sup>A RNA methylation regulators. The signature divided patients into low- and high-risk group. High-risk patients had a worse prognosis than the low-</pubmed_abstract><journal>PeerJ</journal><pubmed_title>The m&lt;sup>6&lt;/sup>A-related gene signature for predicting the prognosis of breast cancer.</pubmed_title><pmcid>PMC8183431</pmcid><funding_grant_id>81602551</funding_grant_id><funding_grant_id>HAB201816</funding_grant_id><funding_grant_id>QL201810</funding_grant_id><pubmed_authors>Feng J</pubmed_authors><pubmed_authors>Zhong S</pubmed_authors><pubmed_authors>Zhou S</pubmed_authors><pubmed_authors>Lin Z</pubmed_authors><pubmed_authors>Chen H</pubmed_authors><pubmed_authors>Mao L</pubmed_authors></additional><is_claimable>false</is_claimable><name>The m&lt;sup>6&lt;/sup>A-related gene signature for predicting the prognosis of breast cancer.</name><description>N6-methyladenosine (m&lt;sup>6&lt;/sup>A) modification has been shown to participate in tumorigenesis and metastasis of human cancers. The present study aimed to investigate the roles of m&lt;sup>6&lt;/sup>A RNA methylation regulators in breast cancer. We used LASSO regression to identify m&lt;sup>6&lt;/sup>A-related gene signature predicting breast cancer survival with the datasets downloaded from Gene Expression Omnibus and The Cancer Genome Atlas (TCGA). RNA-Seq data of 3409 breast cancer patients from GSE96058 and 1097 from TCGA were used in present study. A 10 m&lt;sup>6&lt;/sup>A-related gene signature associated with prognosis was identified from 22 m&lt;sup>6&lt;/sup>A RNA methylation regulators. The signature divided patients into low- and high-risk group. High-risk patients had a worse prognosis than the low-</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2026-05-08T00:19:46.559Z</modification><creation>2022-02-10T15:42:36.329Z</creation></dates><accession>S-EPMC8183431</accession><cross_references><pubmed>34141492</pubmed><doi>10.7717/peerj.11561</doi></cross_references></HashMap>